ELTX Elicio Therapeutics
- 5.720
- +0.050+0.88%
Elicio Therapeutics News
Elicio Therapeutics | SCHEDULE 13G: Others
Elicio Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Venkatesan Jay
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DeMuth Peter
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON KAREN J
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ADAMS JULIAN
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ashe Carol Gail
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RUFFOLO ROBERT R
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina
Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nissenson Allen
Elicio Therapeutics | 424B3: Prospectus
Elicio Therapeutics | 8-K: Current report
Elicio Therapeutics | EFFECT: Others
Elicio Therapeutics | CORRESP: CORRESP
Elicio Therapeutics | UPLOAD: Others
Elicio Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Elicio Therapeutics | 10-Q: Q3 2024 Earnings Report
No Data